FormWeb • eprosartan-hydroCHLOROthiazide

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

eprosartan-hydroCHLOROthiazide

eprosartan-hydroCHLOROthiazide

Restricted Angiotensin II Receptor Antagonist/Hydrochlorothiazide Formulary
Restricted Teveten HCT --> Restricted to NO SUB orders.
Therapeutic Interchange

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Teveten HCT	TABLET, ORAL	600 mg-12.5 mg, 600 mg-25 mg

VIEW MORE Angiotensin II Receptor Antagonists, Thiazide Diuretics

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

eprosartan-hydroCHLOROthiazide (Teveten HCT)

600 mg-12.5 mg tablet oral Daily
600 mg-25 mg tablet oral Daily

losartan-hydroCHLOROthiazide (Hyzaar)

50 mg-12.5 mg tablet oral Daily
losartan 50 mg PLUS hydroCHLOROthiazide 25 mg (dispensed separately)

Reviewed: April 27, 2010.

Last updated: Dec. 20, 2017

Black Box Warning: Eprosartan: pregnancy risk

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.